Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2012 2
2013 1
2014 6
2015 6
2016 6
2017 5
2018 2
2019 4
2020 6
2021 7
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Targeting E-selectin to Tackle Cancer Using Uproleselan.
Muz B, Abdelghafer A, Markovic M, Yavner J, Melam A, Salama NN, Azab AK. Muz B, et al. Cancers (Basel). 2021 Jan 18;13(2):335. doi: 10.3390/cancers13020335. Cancers (Basel). 2021. PMID: 33477563 Free PMC article. Review.
Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy.
Alhallak K, Sun J, Wasden K, Guenthner N, O'Neal J, Muz B, King J, Kohnen D, Vij R, Achilefu S, DiPersio JF, Azab AK. Alhallak K, et al. Among authors: muz b. Leukemia. 2021 Aug;35(8):2346-2357. doi: 10.1038/s41375-021-01127-2. Epub 2021 Jan 21. Leukemia. 2021. PMID: 33479469 Free PMC article.
Molecularly targeted therapies in multiple myeloma.
de la Puente P, Muz B, Azab F, Luderer M, Azab AK. de la Puente P, et al. Among authors: muz b. Leuk Res Treatment. 2014;2014:976567. doi: 10.1155/2014/976567. Epub 2014 Apr 16. Leuk Res Treatment. 2014. PMID: 24829804 Free PMC article. Review.
Nanoparticle T cell engagers for the treatment of acute myeloid leukemia.
Alhallak K, Sun J, Muz B, Jeske A, Yavner J, Bash H, Park C, Lubben B, Adebayo O, Achilefu S, DiPersio JF, Azab AK. Alhallak K, et al. Among authors: muz b. Oncotarget. 2021 Sep 14;12(19):1878-1885. doi: 10.18632/oncotarget.28054. eCollection 2021 Sep 14. Oncotarget. 2021. PMID: 34548905 Free PMC article.
45 results